Baolingbao Biology Co.,Ltd.

¥8.77As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002286Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (4.66%)
Div yield 1.37%
ROE 5.76%
Biotechnology
Beta (5Y) 0.68
PE TTM 24.44
TSR TTM (8.72%)
Mkt cap ¥3.332B
ROIC 6.56%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥11
21.12%
(38.68%)
Hold 7|5|1|7|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.08
0.09
0.09
0.09
7.80%
4.52%
7.41%
10.28%
Revenue¥M
221.0
224.6
224.5
218.5
2.93%
3.10%
5.44%
3.64%
Peers (US$499.5M)
Cap (US$)
PE
506.5M
66.46x
497.2M
623.0x
Capital
TTM
5Y
10Y
Leveragex
5.726
(0.728)
(0.528)
EBIT/Intx
0.794
0.342
0.303
Own earn%
(11.73)
(34.42)
(55.73)
Sh yield%
29.86
30.54
28.30
Owners
Insiders/Inst%
14.72
48.67
Short interest%
2.69
SBC / revenue%
2.13
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
23–29
$1 testx
—
Incr. ROIC%
2